1. Home
  2. NWPX vs ALT Comparison

NWPX vs ALT Comparison

Compare NWPX & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWPX
  • ALT
  • Stock Information
  • Founded
  • NWPX 1966
  • ALT 1997
  • Country
  • NWPX United States
  • ALT United States
  • Employees
  • NWPX N/A
  • ALT N/A
  • Industry
  • NWPX Steel/Iron Ore
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWPX Industrials
  • ALT Health Care
  • Exchange
  • NWPX Nasdaq
  • ALT Nasdaq
  • Market Cap
  • NWPX 420.8M
  • ALT 327.4M
  • IPO Year
  • NWPX 1995
  • ALT N/A
  • Fundamental
  • Price
  • NWPX $51.82
  • ALT $3.57
  • Analyst Decision
  • NWPX Hold
  • ALT Strong Buy
  • Analyst Count
  • NWPX 1
  • ALT 6
  • Target Price
  • NWPX $55.00
  • ALT $17.40
  • AVG Volume (30 Days)
  • NWPX 51.4K
  • ALT 2.3M
  • Earning Date
  • NWPX 10-29-2025
  • ALT 11-11-2025
  • Dividend Yield
  • NWPX N/A
  • ALT N/A
  • EPS Growth
  • NWPX 32.83
  • ALT N/A
  • EPS
  • NWPX 3.32
  • ALT N/A
  • Revenue
  • NWPX $499,125,000.00
  • ALT $20,000.00
  • Revenue This Year
  • NWPX $4.00
  • ALT N/A
  • Revenue Next Year
  • NWPX $3.96
  • ALT $761,880.20
  • P/E Ratio
  • NWPX $15.72
  • ALT N/A
  • Revenue Growth
  • NWPX 5.83
  • ALT N/A
  • 52 Week Low
  • NWPX $36.97
  • ALT $2.90
  • 52 Week High
  • NWPX $57.76
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • NWPX 55.17
  • ALT 44.06
  • Support Level
  • NWPX $51.14
  • ALT $3.54
  • Resistance Level
  • NWPX $53.02
  • ALT $3.72
  • Average True Range (ATR)
  • NWPX 1.52
  • ALT 0.16
  • MACD
  • NWPX -0.39
  • ALT 0.01
  • Stochastic Oscillator
  • NWPX 39.00
  • ALT 10.94

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: